Home Newsfeeds Shell CEO Van Beurden Prepares to Step Down Next Year

Shell CEO Van Beurden Prepares to Step Down Next Year

-Reuters https://www.reuters.com/business/energy/exclusive-shells-ceo-van-beurden-prepares-step-down-next-year-sources-2022-09-02/

byCharles Gross

September 2, 2022

1 minute read

-Reuters

https://www.reuters.com/business/energy/exclusive-shells-ceo-van-beurden-prepares-step-down-next-year-sources-2022-09-02/

Arvinas Releases Early Cut Data Showing Encouraging Efficacy In Prostate Cancer With Certain Mutations

By Vandana Singh

June 8, 11:05 AM

Arvinas Inc (NASDAQ: ARVN) announced interim data from its Phase 1/2 dose escalation and expansion trial of ARV-766 in metastatic

ARVN

Bank of N.T Butterfield Q3 Adj. EPS $1.16, Sales $140.40M

By Michael Horton

October 31, 4:32 PM

Bank of N.T Butterfield (NYSE:NTB) reported quarterly earnings of $1.16 per share which beat the analyst consensus estimate of $(1.64) by 170.73 percent. This is a 45 percent increase over earnings of $0.80 per share

NTB

Citigroup Initiates Coverage On Larimar Therapeutics with Neutral Rating, Announces Price Target of $4

By Benzinga Newsdesk

December 13, 2:14 PM

Citigroup analyst Samantha Semenkow initiates coverage on Larimar Therapeutics (NASDAQ:LRMR) with a Neutral rating and announces Price Target of $4.

LRMR

Why Are Impinj Shares Plunging Today

By Anusuya Lahiri

April 27, 12:07 PM

Impinj, Inc (NASDAQ: PI) shares are trading lower Thursday after releasing mixed first-quarter results and an outlook that trailed expectations.

Shell CEO Van Beurden Prepares to Step Down Next Year

Related Posts

Arvinas Releases Early Cut Data Showing Encouraging Efficacy In Prostate Cancer With Certain Mutations

Bank of N.T Butterfield Q3 Adj. EPS $1.16, Sales $140.40M

Citigroup Initiates Coverage On Larimar Therapeutics with Neutral Rating, Announces Price Target of $4

Why Are Impinj Shares Plunging Today